/ Reports / Live Cell Imaging Market By Product...

Live Cell Imaging Market By Product (Devices, Consumables, Software), By Technology (Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-Content Analysis, Ratiometric Imaging, Fluorescence In Situ Hybridization, Total Internal Reflection Fluorescence Microscopy, Other), By Usage Area (Hospitals And Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

author

Credence Research Inc

date

2 years ago

delivery time

1 business day

The purpose of this research study titled ‘Live Cell Imaging Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global live cell imaging market. This report presents and analyzes the major trends prevalent in the global live cell imaging market and the market size and forecast.

 

This report categorizes the global live cell imaging market in terms of products, technologies, usage areas and geographical distribution. Based on product types, the global live cell imaging market is categorized into devices (microscopes, standalone systems, image-capturing devices, and cell analyzers), consumables (assays, reagents and kits, media, and other consumables) and software. 

 

fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high-content analysis (HCA), ratiometric imaging, fluorescence in situ hybridization (FISH), total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE) and others are the chief cell imaging technologies studied in this report. Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies and Academic and research institutes are the major usage areas for live cell imaging. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

 

Geographically, the global live cell imaging market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa
    •  

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of product, technology, usage area and constituent region/country level markets.

 

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global live cell imaging market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the live cell imaging market. The key players profiled in this report are ATTO Corporation, BioTek Instruments, Biological Industries, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, GE Healthcare, Enzo Life Sciences, Leica Microsystems, Nikon Corporation, Olympus Corporation, PerkinElmer, Thermo Fisher Scientific, and ZEISS International.

 

The live cell imaging market is studied for the following techniques:

  • Fluorescence Recovery After Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High-content Analysis (HCA)
  • Ratiometric Imaging
  • Fluorescence In Situ Hybridization (FISH)
  • Total Internal Reflection Fluorescence Microscopy (TRIF)
  • Multiphoton Excitation Microscopy (MPE)
  • Other Technologies

 

Among the considered technologies fluorescence resonance energy transfer (FRET) accounted for the largest revenue share of the market. The market is anticipated to witness robust growth during the forecast period due to ever rising prevalence of chronic diseases, growth in demand for imaging techniques with determining spatial proximity at protein level and proliferation of related industries such as pharmaceuticals (drug discovery) and biotechnology. 

 

Growth in demand for monoclonal antibodies, and rising research and development budgets of pharmaceutical and biotechnology companies will add to the growth of this market. Furthermore, adoption of high content screening for research purposes, in personalized medicine will be the highest in Asia Pacific markets, on the ground of growing research outsourcing in the region. On the other hand, high costs and lack of skilled technicians will likely hold back the growth of this market.

 

North America currently dominates the global live cell imaging market. Existence of developed pharmaceutical and biotechnology research infrastructure is the prime contributor to the dominance of the region on the global front. Intensive funding for research and development touting novel drug and biotechnology discoveries in the region is an additional market driver. On the other hand, Asia Pacific is the fastest progressing market for live cell imaging. Growth in R&D initiatives in the region and further proliferation of contract research outsourcing to of Asia Pacific live cell imaging market. Additionally, Europe market will majorly witness growth on the ground of trend of perpetual adoption of latest life science technologies in Western Europe.

 

The detailed regional classification of the global live cell imaging market is as follows:

  • North America (U.S. & Canada)
  • Europe (EU 7, CIS, and Rest of Europe)
  • Asia-Pacific (China, India, Japan and Rest of Asia Pacific)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
  • Latin America (Brazil, Mexico, and Rest of Latin America)

Licenses

$

Report Actions

Reviews

5

1 reviews

15 September 2022

Douglas Insights Internal Team Evaluation of this publisher

5

Report Quality

5

Money Value

5

Support

5

Request a sample
or customization

Inquiry before buying